Future studies will need to identify the specific B cell subset-derived immune responses against CAC in MDR1A deficiency, which may include several tumoricidal mechanisms, such as production of granzyme B [82] and anti-tumor antibodies [83]. This evidence concerns the gene GZMB and neoplasm.